MAIA Biotechnology, Inc. (MAIA)
1.15
+0.02
(+1.77%)
USD |
NYAM |
Oct 23, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Price : 1.15 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.13 | 1.15 | 1.12 | 1.15 | 141088.0 |
| Oct 22, 2026 | 1.14 | 1.15 | 1.12 | 1.13 | 92282.00 |
| Oct 21, 2026 | 1.13 | 1.15 | 1.06 | 1.14 | 107871.0 |
| Oct 20, 2026 | 1.08 | 1.13 | 1.07 | 1.12 | 184537.0 |
| Oct 19, 2026 | 1.09 | 1.10 | 1.06 | 1.07 | 799140.0 |
| Oct 16, 2026 | 1.13 | 1.15 | 1.08 | 1.10 | 363522.0 |
| Oct 15, 2026 | 1.10 | 1.15 | 1.10 | 1.12 | 296931.0 |
| Oct 14, 2026 | 1.15 | 1.16 | 1.10 | 1.12 | 628704.0 |
| Oct 13, 2026 | 1.18 | 1.18 | 1.15 | 1.16 | 277469.0 |
| Oct 12, 2026 | 1.22 | 1.22 | 1.16 | 1.18 | 229957.0 |
| Oct 09, 2026 | 1.16 | 1.24 | 1.16 | 1.22 | 375298.0 |
| Oct 08, 2026 | 1.15 | 1.16 | 1.13 | 1.15 | 677144.0 |
| Oct 07, 2026 | 1.17 | 1.22 | 1.16 | 1.18 | 359677.0 |
| Oct 06, 2026 | 1.20 | 1.21 | 1.175 | 1.19 | 227156.0 |
| Oct 05, 2026 | 1.17 | 1.21 | 1.17 | 1.18 | 531014.0 |
| Oct 02, 2026 | 1.19 | 1.21 | 1.17 | 1.19 | 405026.0 |
| Oct 01, 2026 | 1.18 | 1.22 | 1.15 | 1.17 | 781506.0 |
| Sep 30, 2026 | 1.17 | 1.19 | 1.15 | 1.18 | 691458.0 |
| Sep 29, 2026 | 1.20 | 1.215 | 1.15 | 1.15 | 677550.0 |
| Sep 28, 2026 | 1.23 | 1.264 | 1.18 | 1.18 | 1.011M |
| Sep 25, 2026 | 1.27 | 1.33 | 1.20 | 1.20 | 920684.0 |
| Sep 24, 2026 | 1.31 | 1.33 | 1.25 | 1.25 | 594997.0 |
| Sep 23, 2026 | 1.35 | 1.36 | 1.30 | 1.32 | 627035.0 |
| Sep 22, 2026 | 1.33 | 1.37 | 1.31 | 1.37 | 940373.0 |
| Sep 21, 2026 | 1.35 | 1.38 | 1.30 | 1.33 | 1.143M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| PEG Ratio | -0.2487 |
| Price to Book Value | 3.383 |
| Earnings Yield | -55.11% |
| Market Cap | 69.94M |
| PEGY Ratio | -0.2487 |